Literature DB >> 27622556

Glutathione Activatable Photosensitizer-Conjugated Pseudopolyrotaxane Nanocarriers for Photodynamic Theranostics.

Hongxin Tong1, Yangjun Chen1, Zuhong Li1, Huan Li1, Tingting Chen1, Qiao Jin1, Jian Ji1.   

Abstract

Photodynamic theranostics has recently been extensively explored as a promising approach for precise localization and therapy. Herein, glutathione (GSH) activatable photosensitizer (PS)-conjugated pseudopolyrotaxane nanocarriers (α-CD-ss-Ce6 NPs) are reported for enhanced photodynamic theranostics by taking advantage of the noncovalent interactions between α-cyclodextrin (α-CD) and poly(ethylene glycol). The designed α-CD-ss-Ce6 NPs are nonactivated and stable during circulation but exhibited strong photodynamic theranostics through GSH activating after arriving at tumor site. More importantly, compared to free chlorin e6 (Ce6), such kind of pseudopolyrotaxane nanocarrier can dramatically enhance Ce6 accumulation in tumor and prolong its tumor retention time, demonstrating excellent therapeutic effects after light irradiation. Overall, the designed GSH activatable PS-conjugated pseudopolyrotaxane nanocarrier possessing high-performance photodynamic therapeutic efficacy together with reduced side effects offers a promising alternative for photodynamic theranostics.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  activatable; chlorin e6; photodynamic theranostics; pseudopolyrotaxane nanocarriers

Mesh:

Substances:

Year:  2016        PMID: 27622556     DOI: 10.1002/smll.201601966

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  8 in total

Review 1.  Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.

Authors:  Xingshu Li; Jihoon Kim; Juyoung Yoon; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2017-03-29       Impact factor: 30.849

2.  Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy.

Authors:  Yong Luo; Zishan Zeng; Ting Shan; Xiaoyu Xu; Jie Chen; Yuanfeng He; Tao Zhang; Zeqian Huang; Guihong Chai; Yanjuan Huang; Yanfang Zhao; Chunshun Zhao
Journal:  Theranostics       Date:  2022-05-01       Impact factor: 11.600

Review 3.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

4.  pH-Responsive hyperbranched polypeptides based on Schiff bases as drug carriers for reducing toxicity of chemotherapy.

Authors:  Rui Yan; Xinyi Liu; Junjie Xiong; Qiyi Feng; Junhuai Xu; Haibo Wang; Kai Xiao
Journal:  RSC Adv       Date:  2020-04-06       Impact factor: 4.036

5.  Sequential Modulations of Tumor Vasculature and Stromal Barriers Augment the Active Targeting Efficacy of Antibody-Modified Nanophotosensitizer in Desmoplastic Ovarian Carcinoma.

Authors:  Yue Yan; Binlong Chen; Zenghui Wang; Qingqing Yin; Yaoqi Wang; Fangjie Wan; Yulin Mo; Bo Xu; Qiang Zhang; Siling Wang; Yiguang Wang
Journal:  Adv Sci (Weinh)       Date:  2020-12-23       Impact factor: 16.806

6.  Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer.

Authors:  Wenfeng Jia; Rui Liu; Yushan Wang; Chuan Hu; Wenqi Yu; Yang Zhou; Ling Wang; Mengjiao Zhang; Huile Gao; Xiang Gao
Journal:  Acta Pharm Sin B       Date:  2022-03-17       Impact factor: 14.903

Review 7.  α-Cyclodextrin-Based Polypseudorotaxane Hydrogels.

Authors:  Adrian Domiński; Tomasz Konieczny; Piotr Kurcok
Journal:  Materials (Basel)       Date:  2019-12-28       Impact factor: 3.623

Review 8.  Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.

Authors:  Paromita Sarbadhikary; Blassan P George; Heidi Abrahamse
Journal:  Theranostics       Date:  2021-08-26       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.